Phibro Animal Health (Phibro Animal Health) GF Value Rank : 7 (As of May. 11, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Phibro Animal Health GF Value Rank?

Phibro Animal Health has the GF Value Rank of 7.

The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Phibro Animal Health's GF Value Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Phibro Animal Health's GF Value Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Phibro Animal Health's GF Value Rank falls into.

Phibro Animal Health GF Value Rank Related Terms

Thank you for viewing the detailed overview of Phibro Animal Health's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Phibro Animal Health (Phibro Animal Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phibro Animal Health Corp (NAS:PAHC) » Definitions » GF Value Rank

Comparable Companies

Traded in Other Exchanges

PB8:Germany

Address

300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712

Website

https://www.pahc.com

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Executives

Judith Weinstein	officer: See Remarks	C/O PHIBRO ANIMAL HEALTH CORP, 300 FRANK W. BURR BOULEVARD, STE 21, TEANECK NJ 07666
Alejandro Bernal	director	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
E Thomas Corcoran	director
Larry Lee Miller	officer: Chief Operating Officer	8 HAZELWOOD COURT, WARREN NJ 07059
Damian Finio	officer: Chief Financial Officer	C/O IGI LABORATORIES, INC., 105 LINCOLN AVENUE, BUENA NJ 08310
Robin Aukerman	officer: President,North America Region	C/O PHIBRO, GLENPOINTE CENTRE EAST, 3RD FL, 300 FRANK W. BURR BLVD, STE 21, TEANECK NJ 07666
Daniel M Bendheim	director, officer: Exec. VP, Corporate Strategy	300 FRANK W. BURR BOULEVARD, SUITE 21, TEANECK NJ 07666
Dean J Warras	officer: Pres Animal Health & Nutr N.A.	5113 SPYGLASS HILL, QUINCY IL 62305
Jack Bendheim	director, 10 percent owner, officer: President and CEO	C/O EMPIRE RESOURCES, INC., 1 PARKER PLAZA, SUIET 10, FORT LEE NJ 07024
Bfi Co., Llc	10 percent owner	300 FRANK W. BURR BLVD., STE 21, TEANECK NJ 07666
Jonathan Bendheim	director	GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ 07666
Anthony Andolino	officer: SEE REMARKS	GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., STE 21, TEANECK NJ 07666
Richard G Johnson	officer: Chief Financial Officer	7 WEST 96TH STREET, APT. 11C, NEW YORK NY 10025
Gerald K Carlson	director	2496 OLD BEACH ROAD, WAYZATA MN 55391
Thomas G Dagger	officer: SVP, Gen Counsel and Corp Sec	41 WILCOX DRIVE, MOUNTAIN LAKES NJ 07046